Preclinical pharmacokinetics and biodistribution studies of 89Zr-labeled pembrolizumab for human dosimetry estimation

被引：0
|
作者：
Ehlerding, Emily [1 ]
England, Christopher [1 ]
Hernandez, Reinier [1 ]
Graves, Stephen [2 ]
Barnhart, Todd [1 ]
Cai, Weibo [1 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1023
引用
收藏
页数：2
相关论文
共 50 条
  • [21] 89Zr immuno-PET:: Comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies
    Verel, I
    Visser, GWM
    Boellaard, R
    Stigter-van Walsum, M
    Snow, GB
    van Dongen, GAMS
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (08) : 1271 - 1281
  • [22] Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice
    Karmani, Linda
    Labar, Daniel
    Valembois, Vanessa
    Bouchat, Virginie
    Nagaswaran, Praveen Ganesh
    Bol, Anne
    Gillart, Jacques
    Leveque, Philippe
    Bouzin, Caroline
    Bonifazi, Davide
    Michiels, Carine
    Feron, Olivier
    Gregoire, Vincent
    Lucas, Stephane
    Borght, Thierry Vander
    Gallez, Bernard
    CONTRAST MEDIA & MOLECULAR IMAGING, 2013, 8 (05) : 402 - 408
  • [23] Quantitative and correlative biodistribution analysis of 89Zr-labeled mesoporous silica nanoparticles intravenously injected into tumor-bearing mice
    Kramer, Larissa
    Winter, Gordon
    Baur, Benjamin
    Kuntz, Andrea J.
    Kull, Thomas
    Solbach, Christoph
    Beer, Ambros J.
    Linden, Mika
    NANOSCALE, 2017, 9 (27) : 9743 - 9753
  • [24] Preclinical development of a 89Zr-labeled human antibody as a novel immuno-PET agent for noninvasive cancer detection and monitoring response to treatment
    Singh, Abhay Kumar
    Lewis, Calvin D.
    Boas, Cristian Awv
    Diebolder, Philipp
    Jethva, Prashant N.
    Rhee, Aaron
    Song, Jong Hee
    Goo, Young Ah
    Li, Shunqiang
    Liu, Yongjian
    Rogers, Buck
    Kapoor, Vaishali
    Hallahan, Dennis E.
    CANCER RESEARCH, 2023, 83 (07)
  • [25] Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis
    Vizier, Romane
    Adumeau, Pierre
    Denat, Franck
    Goncalves, Victor
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 96-97 : S97 - S97
  • [26] Photoaffinity labeling for the site-specific bioconjugation of 89Zr-labeled radioimmunoconjugates
    Delaney, Samantha
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 114 : S17 - S18
  • [27] PET Imaging of Acidic Tumor Environment With 89Zr-labeled pHLIP Probes
    Bauer, David
    Visca, Hannah
    Weerakkody, Anuradha
    Carter, Lukas M.
    Samuels, Zachary
    Kaminsky, Spencer
    Andreev, Oleg A.
    Reshetnyak, Yana K.
    Lewis, Jason S.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Site-Specific Photoaffinity Bioconjugation for the Creation of 89Zr-Labeled Radioimmunoconjugates
    Samantha Delaney
    Ábel Nagy
    Amelie Eriksson Karlström
    Brian M. Zeglis
    Molecular Imaging and Biology, 2023, 25 : 1104 - 1114
  • [29] Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with 89Zr-Labeled Trastuzumab-DM1: A Comparison with 89Zr-Labeled Trastuzumab
    Al-Saden, Noor
    Lam, Karen
    Chan, Conrad
    Reilly, Raymond M.
    MOLECULAR PHARMACEUTICS, 2018, 15 (08) : 3383 - 3393
  • [30] Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β
    Muns, Joey A.
    Schooten, Erik
    van Dasselaar, Rychon D. J.
    Noordman, Yvet E.
    Adamzek, Kevin
    Eibergen, Arthur C.
    Pronk, Sebas D.
    Cali, Sagel
    Sijbrandi, Niels J.
    Merkul, Eugen
    Oliveira, Sabrina
    van Bergen en Henegouwen, Paul M. P.
    Takkenberg, R. Bart
    Verheij, Joanne
    van de Graaf, Stan F. J.
    Nijmeijer, Bart A.
    van Dongen, Guus A. M. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, : 3545 - 3558
12345